Cellectis SA (CLLS)

4.07 -0.02 (-0.37%) USD  |  NASDAQ  |  Jan 16, 16:00
3.90 -0.17 (-4.18%) Pre-Market: 20:00
More

Cellectis Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for CLLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
EDAP TMS SA Upgrade
DBV Technologies SA --
Genfit SA Upgrade
Ascendis Pharma A/S Upgrade
Akari Therapeutics Plc --